1Jiang XC, Qin SC, Qiao CP, et al. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid transfer protein deficiency. Nature Medicine, 2001, 7: 847-852.
2Murdoch SJ, Carr MC, Hokanson JE, et al. PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J Lipid Res, 2000,41:237-244.
3Colhoun H M,Scheek L,Rubens MB,et al. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes, 2001,50: 652-659.
4Bradley MN, Hong C, Chen M, et al. Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol over load in mice lacking LXRα and apoE. J Clin Invest, 2007, 117:2337-2346.
5Urizar NL, Dowhan DH, Moore DD. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem, 2000, 275: 39313-39317.
6Mak PA, Kast-Woelbern HR, Anisfeld AM, et al. Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors. J Lipid Res ,2002,43:2037-2041.
7Bouly M,Masson D,Gross B,et al. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. J Biol Chem,2001,276:25841-25847.
8Vuletic S,Jin LW,Marcovina SM. Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease. J Lipid Res,2003,44: 1113 -1123.
9Qin SC,Kawano K,Bruce C, et al. Phospholipid transfer protein gene knock-out mice have low density lipoprotein levels, due to hypercatabolism, and accumulate apoA-Ⅳ-rich lamellar lipoproteins. J Lipid Res,2000,41:269-276.
10Dallinga-Thie GM,van Tol A, Hattori H, et al. Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E? Diabetes,2006,55 : 1491-1496.
4Hartford M,Wiklund O,Mattsson L,et al. CRP,interieukin- 6,se- cretory Phospholipase A2 group ⅡA,and intercellular adhesion molecule-lduring the early Phase of acute coronary syndromes and long-term follow-up [ J ]. Int J Cardiol, 2006 : 108 (i) : 55-62.
5Hartford M,Wiklund O,Mattsson L,et al. CRP,interieukin- 6,se- cretory Phospholipase A2 group ⅡA,and intercellular adhesion molecule-1 in the Prediction of late outcome events after acute coro- nary syndromes [ J ]. J Intern Med, 2007,262(5 ) : 526-536.
6Schlitt A,Liu J,Yan D,et al. Anti-inflammatory effects of phospho- lipid transfer protein deficiency in mice [J]. Biochim Biophys Acta, 2005,1733(2) : 187-191.
7Han SH, Quan MJ, Koh KK. Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor-alpha activators [ J ].Hy- pertension, 2005,46 (5) : 1086.
8Schlitt A, Bickel C, Thumma P,et al. High plasma phospholipid trans- fer protein levels as a risk factor for coronary artery disease[J].Arte- rioscler Thromb Vasc Biol, 2003,23 (10) : 1857-1862.
9Qin SC, Kawano K, Bruce C, et al. Phospholipid transfer protein gene knock-out mice have low-density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV- rich lamellar lipoproteins[J]. J Lipid Res, 2000, 41(2) : 269 - 276.
10Yang XP, Yan D, Qiao C, et al. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer pro- tein overexpression [ J ]. Arterioscler Thromb Vasc Biol, 2003, 23(9) :1601 - 1607.
